Long QT Syndrome News and Research

RSS
Long QT syndrome (LQTS) is a disease that affects the normal heart rhythm and electrical activity. It may lead to sudden onset and dangerous arrhythmias (irregularities of heart rate and rhythm) which may be brought on by triggers like exercise or stress.
FDA grants approval for first drug to treat adults with tardive dyskinesia

FDA grants approval for first drug to treat adults with tardive dyskinesia

New report reveals optimal way to detect young athletes at risk of sudden cardiac death

New report reveals optimal way to detect young athletes at risk of sudden cardiac death

Heart specialists to examine benefit of ECG screening for student athletes

Heart specialists to examine benefit of ECG screening for student athletes

Research shows clear link between heart and the brain of LQTS patients

Research shows clear link between heart and the brain of LQTS patients

Genetic testing worthwhile in sudden cardiac death

Genetic testing worthwhile in sudden cardiac death

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Study: Blackouts, near drownings linked to sudden death risk

Study: Blackouts, near drownings linked to sudden death risk

Researchers find way to predict occurrence of some cardiac arrhythmias

Researchers find way to predict occurrence of some cardiac arrhythmias

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Envarsus XR receives FDA approval for treatment of kidney transplant recipients

Envarsus XR receives FDA approval for treatment of kidney transplant recipients

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Novartis presents positive Phase III results of Farydak therapy at EHA

Novartis presents positive Phase III results of Farydak therapy at EHA

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Jianmin Cui receives $1.7 million NIH grant to study heart's inner mechanisms

Jianmin Cui receives $1.7 million NIH grant to study heart's inner mechanisms

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Janssen announces submission of NDA for three-month paliperidone palmitate

Janssen announces submission of NDA for three-month paliperidone palmitate

Johns Hopkins researchers capture images of protein complex that keeps hearts beating

Johns Hopkins researchers capture images of protein complex that keeps hearts beating